BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Vaxcyte
PCVX
$8.76B
| $64.1M | ﹤0.01% |
2,524,645
+178,028
| +8% | +$4.32M |
|
2502
Cooper-Standard Automotive
CPS
$484M
| $64M | ﹤0.01% |
2,923,341
-90,605
| -3% | -$2.18M |
|
2503
Freshworks
FRSH
$3.51B
| $64M | ﹤0.01% |
+1,500,000
| New | +$67.2M |
|
2504
National Healthcare
NHC
$3.44B
| $64M | ﹤0.01% |
913,847
-6,761
| -0.7% | -$492K |
|
2505
Ezcorp Inc
EZPW
$1.76B
| $63.8M | ﹤0.01% |
8,429,871
-288,806
| -3% | -$1.85M |
|
2506
iShares MSCI China A ETF
CNYA
$207M
| $63.7M | ﹤0.01% |
1,496,919
-326,071
| -18% | -$13.9M |
|
2507
POSCO
PKX
$17.1B
| $63.6M | ﹤0.01% |
922,296
-190,394
| -17% | -$14M |
|
|
CAI
2508
DELISTED
CAI International, Inc.
CAI
| $63.3M | ﹤0.01% |
1,131,894
-24,356
| -2% | -$1.36M |
|
2509
Atlanta Braves Holdings Series B
BATRK
$3.41B
| $63.3M | ﹤0.01% |
2,395,131
-2,861
| -0.1% | -$75.3K |
|
2510
DoubleVerify
DV
$2.04B
| $63.1M | ﹤0.01% |
1,848,438
-1,434,433
| -44% | -$50.7M |
|
2511
Hyliion Holdings
HYLN
$734M
| $63M | ﹤0.01% |
7,497,915
-57,597
| -0.8% | -$531K |
|
2512
Duolingo
DUOL
$6.74B
| $62.5M | ﹤0.01% |
+375,593
| New | +$57M |
|
2513
Omeros
OMER
$1.26B
| $62.4M | ﹤0.01% |
4,525,500
-40,747
| -0.9% | -$610K |
|
|
RUBY
2514
DELISTED
Rubius Therapeutics, Inc
RUBY
| $62.3M | ﹤0.01% |
3,484,480
+48,645
| +1% | +$1.06M |
|
2515
Replimune Group
REPL
$1.42B
| $61.9M | ﹤0.01% |
2,088,855
+107,132
| +5% | +$3.48M |
|
2516
Harmony Biosciences
HRMY
$2.24B
| $61.9M | ﹤0.01% |
1,614,173
+309,428
| +24% | +$9.96M |
|
2517
iShares Select Dividend ETF
DVY
$24B
| $61.8M | ﹤0.01% |
538,439
-1,514
| -0.3% | -$177K |
|
2518
Utz Brands
UTZ
$1.25B
| $61.7M | ﹤0.01% |
3,603,617
-16,512
| -0.5% | -$336K |
|
2519
OrthoPediatrics
KIDS
$653M
| $61.7M | ﹤0.01% |
941,274
+388
| +0% | +$25.2K |
|
2520
Comstock Resources
CRK
$3.99B
| $61.6M | ﹤0.01% |
5,955,189
+370,466
| +7% | +$2.51M |
|
|
BTRS
2521
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $61.5M | ﹤0.01% |
5,783,226
+750,255
| +15% | +$8.66M |
|
|
KRON
2522
DELISTED
Kronos Bio
KRON
| $61.5M | ﹤0.01% |
2,932,521
+110,276
| +4% | +$2.37M |
|
|
FBMS
2523
DELISTED
The First Bancshares, Inc.
FBMS
| $61.4M | ﹤0.01% |
1,583,533
-16,864
| -1% | -$651K |
|
2524
A10 Networks
ATEN
$1.96B
| $61.3M | ﹤0.01% |
4,544,300
-812,060
| -15% | -$10.5M |
|
2525
Shinhan Financial Group
SHG
$35.1B
| $61.2M | ﹤0.01% |
1,817,680
+58,003
| +3% | +$1.94M |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.